Interpace Biosciences, Inc.
IDXG· OTC
Filed Mar 23, 2011 · 10-K · 82 days after period end · 0001054102-11-000023
derived · Computed from the longer spans the company filed.
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2010 · filed Mar 23, 2011 · 82 d after period end
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR